We design, build, and finance bleeding edge technology companies

Start

Meet Invent.

We are Invent.  Think of us as a team of institutional co-founders, incubating new concepts and turning our ideas into businesses.  We construct initial prototypes, craft teams around each idea, and provide access to capital.  Our process is unique, and maximizes efficiencies in how companies are conceived, built, and brought to market.

Invent is a proven partner for entrepreneurs looking to accelerate growth and build long-term value in their businesses. Leveraging our history of launching award-winning, highly acclaimed startups, along with our team’s collective operational expertise and successful entrepreneurial endeavors, Invent has built a powerful platform to support our companies with the strategies and resources that are most vital for success. We provide value that extends beyond capital and work as a team to foster growth.

View our process

Our Process

1. Create

Brainstorm, design, and prototype a new idea

2. Recruit

Tailor the perfect team to take the idea to the next level

3. Invest

Invest up to $250K and offer design, strategic, and infrastructure support.

4. Launch

Drive product awareness and support company growth

Current Portfolio

Press About Our Companies

  • forbes

    Forbes

    (STOCKR is) a startup to democratize the stock market...a Bloomberg for the masses.

    Lori Kozlowski
  • Next Big Thing

    The Next Big Thing

    Revenue.com crowned "The Next Big Thing"

    Paley Center
  • pcmag

    PC MAGAZINE

    Top 100 Website of 2013 (STOCKR)

  • bloomberg

    Bloomberg Businessweek

    (Revenue.com)...could one day emerge as viable competitors to Google

Our team

Demetrios Mallios

CEO

Demetrios Mallios
Alan Lewis

COO

Alan Lewis

News

  • Stockr Wins Startup Competition, Crowned Most Exciting Company
    06 06-2013
    Stockr Wins Startup Competition, Crowned Most Exciting Company

    INVENT-owned start-up, Stockr, beat out 97 other companies at Vator’s Splash LA Competition SANTA MONICA, Calif., June 6, 2013 /PRNewswire/ — Stockr, Inc. (“Stockr”), a portfolio company of technology venture fund INVENT Ventures (IDEA), garnered another accolade on May...

    Read more...
  • 16 05-2013
    VIRURL Launches In Stream Ads for Bloggers

    SANTA MONICA, Calif., May 16, 2013 /PRNewswire/ — VIRURL, a Santa Monica-based native advertising start-up incubated by INVENT Ventures, launches In Stream Ads technology to publish relevant sponsored content directly into blogs after signing up over 100,000 influencers and...

    Read more...
  • 07 03-2013
    Sanguine Closes Seed Financing, Led by INVENT Ventures and Heliant Ventures

    Deal Continues INVENT’s Series of Investments in Emerging Technology Businesses SANTA MONICA, Calif., March 7, 2013 /PRNewswire/ — INVENT Ventures, Inc. (OTC QB: IDEA), a seed-stage venture fund and technology incubator, today announced that it has led the seed...

    Read more...
  • 21 02-2013
    INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences

    VALENCIA, Calif., Feb. 21, 2013 /PRNewswire/ — SANGUINE BIOSCIENCES, INC. (“Sanguine”), a biotechnology company empowering patients in biomedical research, has announced the closing of its seed financing round, led by INVENT Ventures and Heliant Ventures. Sanguine engages research subjects...

    Read more...
  • 10 11-2012
    VIRURL Enhances Branded Advertising Platform with New Recommended Content Add-on for Publishers

    INVENT Portfolio Company, Virurl, Inc. (VIRURL) Announces that its “Slideout” Feature Now Live on Popular “Hollywood Assistants” Tumblr Offers New Revenue Streams to Both Advertisers and Publishers Without Irking Web Users New York, NY, November 10, 2012 –(PR.com)– VIRURL...

    Read more...
  • 07 11-2012
    Sanguine Appoints Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to Clinical Advisory Board and Ethics Committee

    VALENCIA, Calif., Nov. 7, 2012 /PRNewswire/ — Sanguine BioSciences, Inc., a biotechnology company providing transparency to patients in biomedical research, has named Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to its Clinical Advisory Board...

    Read more...
  • 30 10-2012
    Sanguine BioSciences Named Bronze Sponsor of Alzheimer’s Association Walk to End Alzheimer’s™

    VALENCIA, Calif., Oct 30, 2012 /PRNewswire/ — SANGUINE BIOSCIENCES, INC, a biotechnology company providing transparency to patients in biomedical research, was named a Bronze Sponsor by the Alzheimer’s Association California Southland Chapter. The Company is not only contributing financially,...

    Read more...
  • 24 10-2012
    INVENT Changes Trading Symbol to “IDEA”

    Rebranding Reinforces Unique Position as Only Public Company in the US Focused Exclusively on Building Technology StartupsRebranding Reinforces the Silicon Beach Incubator’s Unique Position as the Only Public Company in the United States Focused Exclusively on Building Technology Startups...

    Read more...
  • 26 09-2012
    Los Angeles Syndicate of Technology Inc. Changes Name to INVENT Ventures Inc. to Underscore Focus on Building Transformative Technology Businesses

    Rebranding Reinforces Unique Position as Only Public Company in the US Focused Exclusively on Building Technology Startups SANTA MONICA, Calif., Sept. 25, 2012 /PRNewswire/ — INVENT Ventures Inc. (“INVENT”), a seed-stage venture fund and technology incubator, announced today that...

    Read more...
  • 21 09-2012
    LAST-Incubated Company, VIRURL, Wins at the “Next Big Thing,” a Preeminent Technology Media Conference – Voted Most Exciting New Digital Media Company

    SANTA MONICA, Calif., Sept. 21, 2012 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a seed-stage venture fund and technology incubator, is pleased to announce that today its portfolio company, VIRURL, Inc., (“VIRURL”), along with Branch, was...

    Read more...

Contact us

Invent Ventures, Inc.
1930 Ocean Ave #305
Santa Monica, CA 90405


Your message has been sent. Thank you!